Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 2

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 2
---
 solid year over year growth of 5%, while taking incremental pricing action to mitigate the reimbursement and regulatory environment. In this dynamic environment, we emphasize that the MA program maintains strong bipartisan support and is increasingly popular with Medicare beneficiaries as it delivers high-quality, comprehensive care at an affordable cost. Advancing our CenterWell Strategy The growth of both our primary care and value-based (VBC) home health businesses continues. Our primary care platform experienced significant growth in 2024, now operating 344 centers serving over 390,000 patients, representing year over year growth of 16 percent and 33 percent, respectively. Looking ahead, we will continue to scale our platform through a combination of new center adds, patient growth and expansion of our Independent Physician Association business. As your Board of Directors, we take our responsibilities seriously and are committed to representing our stockholders’ interests over the long-term. Looking ahead, the Board has conviction that the strong core fundamentals and growth outlook for MA and VBC remain intact. Further, we believe that Humana’s platform, unique focus on MA, and expanding CenterWell and Medicaid capabilities will allow us to compete effectively, drive better outcomes for our members and patients, and deliver compelling and sustainable stockholder value over the long-term. We hope you can attend the meeting. However, even if you are unable to join us, we urge you to still exercise your right as a stockholder and vote by telephone, mail or using the Internet. The vote of every stockholder is important. On behalf of the Board, thank you for your investment and continued confidence in Humana’s success.

Notice of 2025 Annual Meeting of Stockholders

| Time and Date: 
 Location:      |     | 1:00 p.m., Eastern Time, on Thursday, April 17, 2025                                                                                                                                                                                                                                                                                                                                        
 www.virtualshareholdermeeting.com/HUM2025                                                                                                                                                                                                                                                                                                                                                   |
|:---------------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Agenda:        |     | 1.  Elect the eleven (11) director nominees named in the proxy statement.   2.  Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025.   3.  Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.   4.  Consider any other business properly brought before the meeting. |
| Record Date: